AbbVie Inc.

ABBV | NYSE

Price Alert Chart Builder DCF Calculator

$265.14

+$0.66 (+0.25%)

Sep 22, 2026, 1:50 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	64.39B	62.82B	61.16B	59.64B	58.33B	57.37B	56.33B	55.53B	55B	54.4B	54.32B	55.14B	56.02B	56.74B	58.05B	57.82B	57.35B	56.73B	56.2B	55.17B	53.73B	50.2B
Cost of Revenue	18.37B	18.42B	18.2B	18.05B	16.96B	16.81B	16.9B	18.21B	20.49B	20.52B	20.42B	18.88B	17.42B	17.35B	17.41B	17.56B	16.93B	17.29B	17.45B	17.81B	18.47B	17.66B
Gross Profit	46.02B	44.4B	42.96B	41.6B	41.37B	40.56B	39.43B	37.32B	34.52B	33.88B	33.9B	36.26B	38.61B	39.39B	40.64B	40.26B	40.42B	39.44B	38.75B	37.36B	35.26B	32.54B
Operating Income	18.88B	17.34B	16.34B	9.04B	10.97B	10.07B	9.14B	13.82B	12.27B	12.79B	12.76B	15.06B	17.39B	16.17B	18.12B	17.69B	17.39B	18.54B	17.92B	16.6B	15.55B	11.86B
Interest Income	270M	265M	266M	299M	356M	514M	648M	742M	770M	648M	540M	444M	350M	276M	186M	105M	53M	38M	39M	41M	40M	49M
Pretax Income	8.7B	5.98B	6.6B	1.66B	3.03B	3.62B	3.72B	7.2B	7.07B	7.53B	6.25B	8B	10.45B	9.02B	13.48B	14.78B	14.07B	14.05B	12.99B	7.21B	6.02B	4.17B
Net Income	6.31B	3.64B	4.23B	2.39B	3.76B	4.2B	4.28B	5.12B	5.34B	5.99B	4.86B	6.51B	8.69B	7.59B	11.84B	13.41B	12.64B	12.48B	11.54B	7.53B	6.66B	5.16B
Selling & General & Admin	14.67B	14.3B	14.01B	13.97B	14.61B	14.73B	14.75B	14.09B	13.26B	13.15B	12.87B	13.1B	13.03B	15.17B	15.26B	15.1B	14.88B	12.63B	12.35B	12.32B	12.08B	12.45B
Research & Development	9.71B	9.5B	9.1B	13.29B	13.1B	12.92B	12.79B	8.23B	7.82B	7.6B	7.96B	7.78B	7.71B	7.86B	7.21B	7.41B	7.82B	7.84B	8.05B	8B	7.69B	8.23B
Other Expenses	2.75B	3.26B	3.51B	5.29B	2.7B	2.83B	2.75B	1.18B	1.17B	341M	317M	316M	479M	196M	56M	57M	328M	432M	432M	432M	-68M	n/a
Operating Expenses	27.14B	27.06B	26.62B	32.56B	30.4B	30.48B	30.29B	23.5B	22.24B	21.09B	21.15B	21.19B	21.22B	23.23B	22.52B	22.57B	23.03B	20.9B	20.83B	20.76B	19.71B	20.67B
Interest Expense	2.92B	2.91B	2.89B	2.88B	2.86B	2.85B	2.81B	2.67B	2.51B	2.33B	2.22B	2.23B	2.23B	2.24B	2.23B	2.24B	2.28B	2.34B	2.42B	2.47B	2.51B	2.52B
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	45.51B	45.48B	44.82B	50.6B	47.36B	47.3B	47.2B	41.71B	42.73B	41.62B	41.56B	40.07B	38.64B	40.57B	39.94B	40.13B	39.96B	38.19B	38.27B	38.57B	38.18B	38.33B
Income Tax Expense	2.38B	2.33B	2.36B	-735M	-741M	-581M	-570M	2.06B	1.72B	1.53B	1.38B	1.48B	1.76B	1.43B	1.63B	1.37B	1.43B	1.56B	1.44B	-331M	-652M	-1B
Shares Outstanding (Basic)	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B
Shares Outstanding (Diluted)	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.77B	1.78B	1.78B	1.78B	1.78B	1.78B	1.78B	1.78B	1.78B	1.78B
EPS (Basic)	3.55	2.04	2.37	1.33	2.11	2.35	2.40	2.88	3	3.37	2.73	3.67	4.90	4.28	6.69	7.58	7.13	7.03	6.49	4.21	3.73	2.86
EPS (Diluted)	3.55	2.04	2.37	1.33	2.11	2.35	2.40	2.88	3	3.37	2.73	3.66	4.88	4.25	6.65	7.52	7.08	6.99	6.45	4.20	3.71	2.84
EBITDA	21.24B	16.92B	17.63B	12.8B	14.16B	14.82B	14.91B	18.23B	18.09B	18.51B	17.17B	19.01B	21.43B	19.8B	24.17B	25.32B	24.56B	24.75B	23.93B	18.29B	17.3B	14.82B
EBIT	13.31B	8.89B	9.49B	4.54B	5.89B	6.47B	6.52B	9.87B	9.57B	9.86B	8.47B	10.23B	12.68B	11.26B	15.71B	17.03B	16.35B	16.39B	15.41B	9.68B	8.53B	6.69B
Depreciation & Amortization	7.92B	8.04B	8.14B	8.25B	8.27B	8.35B	8.39B	8.36B	8.52B	8.65B	8.7B	8.78B	8.75B	8.54B	8.47B	8.29B	8.21B	8.36B	8.52B	8.61B	8.77B	8.13B